Overview
Autosomal recessive multiple pterygium syndrome (also known as Escobar syndrome or Escobar multiple pterygium syndrome) is a rare genetic disorder characterized by the presence of multiple pterygia — webbing of skin across joints — along with other musculoskeletal abnormalities. The condition is present from birth and results from reduced fetal movement during development. Key clinical features include pterygia (skin webs) affecting the neck, elbows, knees, fingers, and armpits, as well as joint contractures (arthrogryposis), short stature, scoliosis or vertebral anomalies, and distinctive facial features including a flat facial profile, downslanting palpebral fissures, and micrognathia (small jaw). Affected individuals may also have cleft palate, cryptorchidism in males, and finger anomalies such as syndactyly or camptodactyly. The condition primarily affects the musculoskeletal system, but can also involve the craniofacial structures and, in some cases, the respiratory system due to restrictive chest wall abnormalities. The syndrome is caused by mutations in the CHRNG gene, which encodes the gamma subunit of the fetal acetylcholine receptor, critical for neuromuscular junction function during prenatal development. Less commonly, mutations in other genes involved in neuromuscular transmission (such as CHRNA1, CHRND, or RAPSN) have been identified. The disorder follows autosomal recessive inheritance, meaning both parents must carry a pathogenic variant for a child to be affected. There is no cure for autosomal recessive multiple pterygium syndrome. Treatment is supportive and symptomatic, focusing on orthopedic management of joint contractures and scoliosis, surgical release of pterygia when they limit mobility, and physical therapy to maximize range of motion. Craniofacial surgery may be needed for cleft palate repair. Prognosis is generally favorable for survival, distinguishing this condition from the lethal form of multiple pterygium syndrome, though the degree of physical disability varies. Long-term follow-up with a multidisciplinary team including orthopedics, genetics, and rehabilitation specialists is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive multiple pterygium syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive multiple pterygium syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive multiple pterygium syndrome.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive multiple pterygium syndrome.
Start the conversation →Latest news about Autosomal recessive multiple pterygium syndrome
No recent news articles for Autosomal recessive multiple pterygium syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal recessive multiple pterygium syndrome
What is Autosomal recessive multiple pterygium syndrome?
Autosomal recessive multiple pterygium syndrome (also known as Escobar syndrome or Escobar multiple pterygium syndrome) is a rare genetic disorder characterized by the presence of multiple pterygia — webbing of skin across joints — along with other musculoskeletal abnormalities. The condition is present from birth and results from reduced fetal movement during development. Key clinical features include pterygia (skin webs) affecting the neck, elbows, knees, fingers, and armpits, as well as joint contractures (arthrogryposis), short stature, scoliosis or vertebral anomalies, and distinctive fac
How is Autosomal recessive multiple pterygium syndrome inherited?
Autosomal recessive multiple pterygium syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal recessive multiple pterygium syndrome typically begin?
Typical onset of Autosomal recessive multiple pterygium syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Autosomal recessive multiple pterygium syndrome?
2 specialists and care centers treating Autosomal recessive multiple pterygium syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.